These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 29513937)

  • 1. Consideration of Antisynthetase Syndrome Features in Classifying Patients as Having Idiopathic Inflammatory Myopathy: Comment on the Article by Lundberg et al.
    Castañeda S; Cavagna L; González-Gay MA;
    Arthritis Rheumatol; 2018 Jun; 70(6):975-976. PubMed ID: 29513937
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to: 'Performance of the 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies in clinical practice' by Hočevar
    Lundberg IE; Bottai M; Tjärnlund A
    Ann Rheum Dis; 2018 Dec; 77(12):e91. PubMed ID: 29317406
    [No Abstract]   [Full Text] [Related]  

  • 3. Response to: 'Detection of myositis-specific antibodies' by Vulsteke
    Tjärnlund A; Rönnelid J; Bottai M; Lundberg IE
    Ann Rheum Dis; 2019 Jan; 78(1):e8. PubMed ID: 29382639
    [No Abstract]   [Full Text] [Related]  

  • 4. 2017 EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: little emphasis on autoantibodies, why?
    Malaviya AN
    Ann Rheum Dis; 2018 Nov; 77(11):e77. PubMed ID: 29170201
    [No Abstract]   [Full Text] [Related]  

  • 5. Response to: '2017 EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: little emphasis on autoantibodies, why?' by Malaviya.
    Lundberg IE; Tjärnlund A
    Ann Rheum Dis; 2018 Nov; 77(11):e78. PubMed ID: 29247124
    [No Abstract]   [Full Text] [Related]  

  • 6. Response to: 'Time to personalise the treatment of anti-MDA-5 associated lung disease' by Lake
    Leclair V; Lundberg IE; Tjärnlund A
    Ann Rheum Dis; 2019 Jun; 78(6):e53. PubMed ID: 29724727
    [No Abstract]   [Full Text] [Related]  

  • 7. Response to: 'Comment on: 'Idiopathic inflammatory myopathies and antisynthetase syndrome: contribution of antisynthetase antibodies to improve current classification criteria' by Greco
    Tjärnlund A; Lundberg IE
    Ann Rheum Dis; 2020 Jul; 79(7):e86. PubMed ID: 31068326
    [No Abstract]   [Full Text] [Related]  

  • 8. Antisynthetase antibodies in clinical laboratories: the importance of clinical correlation and indirect immunofluorescence. Response to: Comment on: 'Idiopathic inflammatory myopathies and antisynthetase syndrome: contribution of antisynthetase antibodies to improve current classification criteria' by Greco
    Greco M; García de Yébenes MJ; Alarcón I; Brandy-García AM; Rúa-Figueroa Í; Loza E; Carmona L
    Ann Rheum Dis; 2020 Jul; 79(7):e87. PubMed ID: 31167759
    [No Abstract]   [Full Text] [Related]  

  • 9. Response to: 'Detection of myositis-specific antibodies: additional notes' by Infantino
    Tjärnlund A; Lundberg IE; Rönnelid J
    Ann Rheum Dis; 2019 Apr; 78(4):e30. PubMed ID: 29615410
    [No Abstract]   [Full Text] [Related]  

  • 10. Detection of myositis-specific antibodies.
    Vulsteke JB; De Langhe E; Claeys KG; Dillaerts D; Poesen K; Lenaerts J; Westhovens R; Van Damme P; Blockmans D; De Haes P; Bossuyt X
    Ann Rheum Dis; 2019 Jan; 78(1):e7. PubMed ID: 29371203
    [No Abstract]   [Full Text] [Related]  

  • 11. Inflammatory Myopathies: New classification criteria developed for research.
    Razzak M
    Nat Rev Rheumatol; 2017 Nov; 13(12):694. PubMed ID: 29158575
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply.
    Tjärnlund A; Bottai M; Lundberg IE
    Arthritis Rheumatol; 2018 Jun; 70(6):976. PubMed ID: 29513922
    [No Abstract]   [Full Text] [Related]  

  • 13. American College of Rheumatology/European League Against Rheumatism Sjögren's Syndrome Classification Criteria May Not Be Adequate for Extraglandular Disease and Necessitate Defining "Seronegative Sjögren's Syndrome": Comment on the Article by Shiboski et al.
    Tezcan ME; Kucuk H; Goker B
    Arthritis Rheumatol; 2017 Jun; 69(6):1341-1342. PubMed ID: 28245349
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial: A New Classification of Adult Autoimmune Myositis.
    Senécal JL; Raynauld JP; Troyanov Y
    Arthritis Rheumatol; 2017 May; 69(5):878-884. PubMed ID: 28382651
    [No Abstract]   [Full Text] [Related]  

  • 15. Nuclear actin aggregation is a hallmark of anti-synthetase syndrome-induced dysimmune myopathy.
    Stenzel W; Preuße C; Allenbach Y; Pehl D; Junckerstorff R; Heppner FL; Nolte K; Aronica E; Kana V; Rushing E; Schneider U; Claeys KG; Benveniste O; Weis J; Goebel HH
    Neurology; 2015 Mar; 84(13):1346-54. PubMed ID: 25746564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to: 'External validation of EULAR/ACR classification criteria for idiopathic inflammatory myopathies' by Luu
    Jinnin M; Ohta A; Kohsaka H
    Ann Rheum Dis; 2022 Apr; 81(4):e60. PubMed ID: 32398284
    [No Abstract]   [Full Text] [Related]  

  • 17. Is RAPID3 a Good Predictor of Radiographic Outcomes in Rheumatoid Arthritis? Comment on the Article by Khawaja et al.
    Baker JF; George MD
    Arthritis Care Res (Hoboken); 2018 Jun; 70(6):957-958. PubMed ID: 28651040
    [No Abstract]   [Full Text] [Related]  

  • 18. Detection of myositis-specific antibodies: additional notes.
    Infantino M; Manfredi M; Grossi V; Benucci M
    Ann Rheum Dis; 2019 Apr; 78(4):e29. PubMed ID: 29535123
    [No Abstract]   [Full Text] [Related]  

  • 19. Detection of myositis-specific antibodies: additional notes.
    Mahler M; Fritzler MJ
    Ann Rheum Dis; 2019 May; 78(5):e45. PubMed ID: 29444906
    [No Abstract]   [Full Text] [Related]  

  • 20. British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy.
    Oldroyd AGS; Lilleker JB; Amin T; Aragon O; Bechman K; Cuthbert V; Galloway J; Gordon P; Gregory WJ; Gunawardena H; Hanna MG; Isenberg D; Jackman J; Kiely PDW; Livermore P; Machado PM; Maillard S; McHugh N; Murphy R; Pilkington C; Prabu A; Rushe P; Spinty S; Swan J; Tahir H; Tansley SL; Truepenny P; Truepenny Y; Warrier K; Yates M; Papadopoulou C; Martin N; McCann L; Chinoy H;
    Rheumatology (Oxford); 2022 May; 61(5):1760-1768. PubMed ID: 35355064
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.